Analyst Price Target is $60.00
▲ +337.64% Upside Potential
This price target is based on 16 analysts offering 12 month price targets for Bayer Aktiengesellschaft in the last 3 months. The average price target is $60.00, with a high forecast of $60.00 and a low forecast of $60.00. The average price target represents a 337.64% upside from the last price of $13.71.
Current Consensus is
The current consensus among 16 polled investment analysts is to buy stock in Bayer Aktiengesellschaft. This rating has held steady since January 2021, when it changed from a Hold consensus rating.
Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by